Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $280M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | 494,424 | $22.22M | 7.9% | $48.81 | +6.1% | COM | 834203309 |
| — | MERUS N V | 463,840 | $19.5M | 7.0% | $42.88 | — | COM | N5749R100 |
| — | INTRA-CELLULAR THERAPIES INC | 219,719 | $18.35M | 6.6% | $66.31 | — | COM | 46116X101 |
| ACLX | ARCELLX INC | 229,785 | $17.62M | 6.3% | $86.39 | 0.0% | COMMON STOCK | 03940C100 |
| NVO | NOVO-NORDISK A S | 200,000 | $17.2M | 6.1% | $113.72 | — | Put | 670100205 |
| NVO | NOVO-NORDISK A S | 200,000 | $17.2M | 6.1% | $113.72 | — | ADR | 670100205 |
| NUVL | NUVALENT INC | 204,045 | $15.97M | 5.7% | $92.60 | +0.9% | COM | 670703107 |
| PCVX | VAXCYTE INC | 162,255 | $13.28M | 4.7% | $79.28 | +25.2% | COM | 92243G108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 56,400 | $13.27M | 4.7% | $197.76 | +33.0% | COM | 02043Q107 |
| AZN | ASTRAZENECA PLC | 190,752 | $12.5M | 4.5% | $69.76 | — | SPONSORED ADR | 046353108 |
| RVMD | REVOLUTION MEDICINES INC | 284,190 | $12.43M | 4.4% | $48.13 | +4.9% | COM | 76155X100 |
| — | VERONA PHARMA PLC | 255,318 | $11.86M | 4.2% | $31.60 | — | SPONSORED ADS | 925050106 |
| INSM | INSMED INC | 167,939 | $11.59M | 4.1% | $57.73 | +24.8% | COM PAR $.01 | 457669307 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 293,851 | $11.34M | 4.1% | $35.82 | +21.7% | COM | 74366E102 |
| XBI | SPDR SER TR | 100,000 | $9.006M | 3.2% | — | — | Put | 78464A870 |
| JANX | JANUX THERAPEUTICS INC | 162,976 | $8.726M | 3.1% | $52.89 | 0.0% | COM | 47103J105 |
| ARGX | ARGENX SE | 11,311 | $6.956M | 2.5% | $387.47 | — | SPONSORED ADR | 04016X101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 45,000 | $6.143M | 2.2% | $117.13 | +5.6% | COM | 64125C109 |
| NVO | NOVO-NORDISK A S | 50,000 | $4.301M | 1.5% | $113.72 | — | Call | 670100205 |
| VKTX | VIKING THERAPEUTICS INC | 90,279 | $3.633M | 1.3% | $28.32 | +101.3% | COM | 92686J106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 50,000 | $2.799M | 1.0% | $55.24 | 0.0% | COM | 76243J105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 45,765 | $2.34M | 0.8% | $39.13 | +43.0% | COM | 22663K107 |
| ELVN | ENLIVEN THERAPEUTICS INC | 102,900 | $2.315M | 0.8% | $25.92 | 0.0% | COM | 29337E102 |
| — | SPRINGWORKS THERAPEUTICS INC | 53,930 | $1.948M | 0.7% | $49.22 | — | COM | 85205L107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 100,000 | $1.917M | 0.7% | $21.74 | 0.0% | COM | 92790C104 |
| TGTX | TG THERAPEUTICS INC | 54,515 | $1.641M | 0.6% | $28.70 | 0.0% | COM | 88322Q108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 216,700 | $1.614M | 0.6% | $10.79 | -13.7% | COM NEW | 30233G209 |
| XENE | XENON PHARMACEUTICALS INC | 40,000 | $1.568M | 0.6% | $46.00 | -10.1% | COM | 98420N105 |
| MREO | MEREO BIOPHARMA GROUP PLC | 421,359 | $1.475M | 0.5% | $3.30 | — | SPON ADS | 589492107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 54,285 | $1.395M | 0.5% | $20.30 | +4.6% | ORDINARY SHARES | N62509109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 80,380 | $1.346M | 0.5% | $15.99 | — | SPONSORED ADS | 152309100 |
| EWTX | EDGEWISE THERAPEUTICS INC | 50,000 | $1.335M | 0.5% | — | — | Put | 28036F105 |
| CRL | CHARLES RIV LABS INTL INC | 6,305 | $1.164M | 0.4% | $226.63 | -15.0% | COM | 159864107 |
| TARS | TARSUS PHARMACEUTICALS INC | 20,811 | $1.152M | 0.4% | $45.42 | 0.0% | COM | 87650L103 |
| ASND | ASCENDIS PHARMA A/S | 7,440 | $1.024M | 0.4% | $151.17 | — | SPONSORED ADR | 04351P101 |
| ANNX | ANNEXON INC | 172,226 | $884K | 0.3% | $5.30 | +16.2% | COM | 03589W102 |
| TECX | TECTONIC THERAPEUTIC INC | 16,650 | $769K | 0.3% | $42.29 | 0.0% | COM | 878972108 |